A phase II study of 5-fluorouracil plus folinic acid in malignant gliomas in adults
- PMID: 7673988
- DOI: 10.1007/BF01059957
A phase II study of 5-fluorouracil plus folinic acid in malignant gliomas in adults
Abstract
Fourteen patients with malignant gliomas were entered on a phase II study of 5-fluorouracil 300-370 mg/m2 plus folinic acid 200 mg/m2 x 5 days q4 weeks. To be eligible, patients could not have received more than 1 prior chemotherapy regimen. A single patient with a recurrent oligodendroglioma responded. Toxicity (predominantly stomatitis, diarrhea, and granulocytopenia) was tolerable and was similar to that seen in studies of 5-fluorouracil plus folinic acid in other tumor types. This regimen has minimal activity in recurrent malignant gliomas.
Similar articles
-
Phase II study of 5-fluorouracil and leucovorin in recurrent primary brain tumor.J Neurooncol. 1996 Dec;30(3):243-6. doi: 10.1007/BF00177275. J Neurooncol. 1996. PMID: 8943099 Clinical Trial.
-
Intravenous carboplatin for recurrent malignant glioma: a phase II study.J Clin Oncol. 1991 May;9(5):860-4. doi: 10.1200/JCO.1991.9.5.860. J Clin Oncol. 1991. PMID: 1849986 Clinical Trial.
-
Weekly high-dose infusional 5-fluorouracil (HD-5-FU) combinations in the treatment of advanced breast cancer: results of phase I/II studies with weekly 24-hour infusion of HD-5-FU plus high-dose folinic acid (FA) alone and in combination with paclitaxel and cisplatin.J Infus Chemother. 1996 Summer;6(3):127-32. J Infus Chemother. 1996. PMID: 9229323 Review.
-
Phase II trial of chronomodulated infusion of 5-fluorouracil and folinic acid in metastatic colorectal cancer.Anticancer Res. 2000 Nov-Dec;20(6C):4649-53. Anticancer Res. 2000. PMID: 11205195 Clinical Trial.
-
A phase II study of 5-fluorouracil plus high-dose folinic acid in the treatment of recurrent small cell lung cancer.Am J Clin Oncol. 1995 Apr;18(2):130-2. doi: 10.1097/00000421-199504000-00007. Am J Clin Oncol. 1995. PMID: 7900705 Clinical Trial.
Cited by
-
Neural Stem Cell-Based Anticancer Gene Therapy: A First-in-Human Study in Recurrent High-Grade Glioma Patients.Clin Cancer Res. 2017 Jun 15;23(12):2951-2960. doi: 10.1158/1078-0432.CCR-16-1518. Epub 2016 Dec 15. Clin Cancer Res. 2017. PMID: 27979915 Free PMC article. Clinical Trial.
-
Current perspectives in gliomas.Med Oncol. 1997 Jun;14(2):103-20. doi: 10.1007/BF02990955. Med Oncol. 1997. PMID: 9330270 Review.
-
Distinct patterns of 1p and 19q alterations identify subtypes of human gliomas that have different prognoses.Neuro Oncol. 2010 Jul;12(7):664-78. doi: 10.1093/neuonc/nop075. Epub 2010 Feb 17. Neuro Oncol. 2010. PMID: 20164239 Free PMC article.
-
Rationally designed pharmacogenomic treatment using concurrent capecitabine and radiotherapy for glioblastoma; gene expression profiles associated with outcome.Clin Cancer Res. 2010 May 15;16(10):2890-8. doi: 10.1158/1078-0432.CCR-09-3151. Epub 2010 May 11. Clin Cancer Res. 2010. PMID: 20460474 Free PMC article. Clinical Trial.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Medical